TS Picks: March 16, 2016

Corrections give belated credit for immunotherapy; mosquitoes have been bugging us long before Zika; the bright side of irreproducibility 

Kerry Grens
Mar 16, 2016


Selections from The Scientist’s reading list:

  • The New England Journal of Medicine is correcting three papers from a team led by the University of Pennsylvania’s Carl June, who is credited with pioneering a cancer immunotherapy. As MIT Technology Review reported this week (March 14), the publications did not appropriately credit the scientists who designed the chimeric antigen receptor critical for the treatment. “It’s been beneficial for immunotherapy,” Dario Campana, one of the now-acknowledged scientists, told Tech Review. “But we developed this receptor. There is no question about that.”  
  • As the Zika virus advances through the Americas, The Washington Post this week (March 14) offered a grim reminder that the pathogen is just the latest malady humans have suffered at the hands—er, bites—of mosquitoes. For a century we have known that the insects can carry deadly diseases, but...